Search

everythinglearnresearchcommunity

for

Search:↓

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

The mesenchymal stem cell secretome may effectively treat various diseases as an alternative to traditional stem cell therapies.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.